Neumora Therapeutics (NMRA) Interest Coverage Ratio (2025 - 2026)
Neumora Therapeutics (NMRA) posted quarterly Interest Coverage Ratio of 28.51 for Q1 2026, up 0.73% quarter-over-quarter from 28.72 in Q4 2025.
Analysis
Neumora Therapeutics (NMRA) Interest Coverage Ratio (2025 - 2026) Analysis & Trends
Neumora Therapeutics' Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 28.51 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio changed N/A year-over-year to 28.51; the TTM figure through Mar 2026 stood at 57.35 (changed N/A YoY), while the FY2025 annual figure was 0.73, up 26.71% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 28.51, up from 28.72 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.22 in Q4 2022, with the low at 57.7 in Q3 2025.
- The 5-year median for Interest Coverage Ratio is 1.26 (2024), against an average of 16.85.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio sank 110.35% in 2024, then plunged 5392.29% in 2025.
- Neumora Therapeutics' Interest Coverage Ratio stood at 0.22 in 2022, then plunged by 166.3% to 0.58 in 2023, then slumped by 81.8% to 1.05 in 2024, then slumped by 2634.05% to 28.72 in 2025, then increased by 0.73% to 28.51 in 2026.
- Business Quant data shows NMRA's Interest Coverage Ratio at 28.51 in Q1 2026, 28.72 in Q4 2025, and 57.7 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Neumora Therapeutics | 243.49 Mn | 243.49 Mn | - | -23.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.18 |
| Mar 31, 2026 | -28.51 |
| Dec 31, 2025 | -28.72 |
| Sep 30, 2025 | -77.24 |
| Jun 30, 2025 | -123.94 |